Venous thromboembolism, chronic liver disease and anticoagulant choice: effectiveness and safety of direct oral anticoagulants versus warfarin

CONCLUSION: While the magnitude of clinical benefit varied across individual DOACs, in adults with acute VTE and chronic liver disease, oral factor Xa inhibitors (as a class or individually) were associated with lower risk of recurrent VTE and major bleeding.PMID:38268519 | PMC:PMC10805675 | DOI:10.1016/j.rpth.2023.102293

Source: Thrombosis and Haemostasis - January 25, 2024 Category: Hematology Authors: Oluwadolapo D Lawal Herbert D Aronow Anne L Hume Fisayomi Shobayo Kelly L Matson Marilyn Barbour Yichi Zhang Xuerong Wen Source Type: research